— Know what they know.
Not Investment Advice
Also trades as: KURN.SW (SIX) · $vol 4M · 0RHR.L (LSE) · $vol 0M

CSBTF OTC

Kuros Biosciences AG
1W: +0.0% 1M: -11.1% 3M: +5.6% YTD: -37.4% 1Y: -15.2% 3Y: +1150.0% 5Y: +879.6%
$24.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 37 · $946.5M mcap · 28M float · 0.0011% daily turnover · Short 98% of daily vol

Balance Sheet Trends

Total Assets
$107M +26.9% ▲
5Y CAGR: +2.6%
Total Liabilities
$40M +56.3% ▲
5Y CAGR: +32.8%
Shareholders Equity
$67M +14.0% ▲
5Y CAGR: -4.6%
Cash & Investments
$16M -10.3% ▼
5Y CAGR: -11.2%
Total Debt
$4M +119.7% ▲
5Y CAGR: +11.0%
Net Debt
-$12M +25.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$29M$24M$14M$17M$16M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$29M$24M$14M$17M$16M
Net Receivables$2M$3M$6M$15M$32M
Inventory$2M$3M$5M$9M$17M
Other Current Assets$171K$271K$1M$3M$1M
Total Current Assets$33M$31M$27M$45M$66M
Property, Plant & Equip.$2M$2M$3M$3M$4M
Goodwill & Intangibles$56M$49M$41M$34M$32M
Long-Term Investments$53M$51M$17M$0$0
Other Non-Current Assets-$58M-$51M-$16M$0$257K
Total Non-Current Assets$58M$52M$44M$40M$42M
Total Assets$91M$83M$71M$85M$107M
— Liabilities —
Accounts Payable$846K$1M$1M$7M$11M
Short-Term Debt$0$0$0$0$518K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$7M$6M$3M$13M$6M
Total Current Liabilities$11M$13M$13M$21M$33M
Long-Term Debt$0$0$0$0$3M
Other Non-Current Liab.$353K$0$3M$3M$0
Total Non-Current Liabilities$3M$1M$2M$5M$7M
Total Liabilities$14M$14M$15M$26M$40M
— Equity —
Common Stock$3M$4M$4M$4M$3M
Retained Earnings-$101M-$116M-$42M-$45M-$30M
Accumulated OCI$0$0$22M$0$41M
Total Stockholders Equity$77M$69M$57M$59M$67M
Total Liabilities & Equity$91M$83M$71M$85M$107M
— Key Metrics —
Total Debt$2M$2M$2M$2M$4M
Net Debt-$26M-$22M-$12M-$16M-$12M
Total Investments$53M$51M$17M$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms